Education
About Us
Working with TipRanks
Follow Us
BioLargo Inc (BLGO)
OTHER OTC:BLGO
BLGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $0.37
Previous CloseN/A
Volume222.28K
Average Volume (3M)212.50K
Market Cap
$70.58M
Enterprise Value$53.45M
Total Cash (Recent Filing)$921.94K
Total Debt (Recent Filing)$5.72M
Price to Earnings (P/E)―
Beta-0.26
Next Earnings
May 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding301,760,380
10 Day Avg. Volume246,901
30 Day Avg. Volume212,500
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.72
Price to Cash Flow (P/CF)-13.50
P/FCF Ratio0.00
Enterprise Value/Market Cap0.76
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.69
Enterprise Value/Ebitda-15.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
BioLargo News
PremiumCompany Announcements
BioLargo Reports Record Revenue Growth in 2024
PremiumCompany Announcements
BioLargo’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
BioLargo Presents at Webcast Investor Conference
PremiumPre-Earnings
BioLargo (BLGO) Q4 Earnings Cheat Sheet
PremiumCompany Announcements
BioLargo Shares Strategic Updates in Investor Webcast---
Options Prices
Currently, No data available
---
Ownership Overview
9.96% Insiders
―
Mutual Funds
0.04% Other Institutional Investors
90.00% Public Companies and
Individual Investors
BLGO FAQ
What was BioLargo Inc’s price range in the past 12 months?
BioLargo Inc lowest stock price was $0.16 and its highest was $0.37 in the past 12 months.
What is BioLargo Inc’s market cap?
BioLargo Inc’s market cap is $70.58M.
When is BioLargo Inc’s upcoming earnings report date?
BioLargo Inc’s upcoming earnings report date is May 14, 2025 which is in 12 days.
How were BioLargo Inc’s earnings last quarter?
BioLargo Inc released its earnings results on Mar 31, 2025. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.006.
Is BioLargo Inc overvalued?
According to Wall Street analysts BioLargo Inc’s price is currently Overvalued.
Does BioLargo Inc pay dividends?
BioLargo Inc does not currently pay dividends.
What is BioLargo Inc’s EPS estimate?
BioLargo Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioLargo Inc have?
BioLargo Inc has 301,760,380 shares outstanding.
What happened to BioLargo Inc’s price movement after its last earnings report?
BioLargo Inc reported an EPS of -$0.006 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BioLargo Inc?
Currently, no hedge funds are holding shares in BLGO
---
BioLargo Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.99%
12-Months-Change
Fundamentals
Return on Equity
-30.61%
Trailing 12-Months
Asset Growth
28.13%
Trailing 12-Months
Company Description
BioLargo Inc
BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. It holds various issued patents, maintains a pipeline of products, and provides full-service environmental engineering services. The company's products include Advanced Oxidation system, a water treatment device that generates a series of oxidative and energetic species of iodine and other molecules; Aqueous Electrostatic Concentrator, a water treatment system that removes per- and poly-fluoroalkyl substances from water; CupriDyne Clean industrial products, which reduce and eliminate tough odors and volatile organic compounds in various industrial settings; and advanced wound care products. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
---
BLGO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
BioLargo's earnings call presented a positive outlook, with significant revenue growth and advancements across its subsidiaries. However, challenges in specific projects and revenue fluctuations in key products indicate areas needing attention. Overall, the sentiment is optimistic with caution regarding operational hurdles.Read More>---
Technical Analysis
---